CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 12 enrolled
Drug / intervention
Methadonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00356083
NCT00356083Phase 3Completed

Opioid Switching From Oral Slow Release Morphine to Oral Methadone May Improve Pain Control in Chronic Non-malignant Pain: a Nine-month Follow-up Study.

Norwegian University of Science and Technology·interventional·Posted Jul 25, 2006·Updated Jul 29, 2016

In Brief

A Phase 3 clinical trial evaluating Methadone for Non-malignant Chronic Pain. Completed, enrolled 12 participants.

Detailed Summary

Patients with non-malignant pain are switched from morphine to methadone with a nine-months' follow-up.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 25, 2006
Enrollment StartJan 1, 2004
Primary CompletionMar 1, 2005
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 19.9 years ago

Interventions

Methadonedrug